Product ID: SQMIG35H2128
Report ID:
SQMIG35H2128 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
121 |
Figures:
77
In January 2024, Verdot, downstream bioprocessing technology company announced the launch of its FlexiPro TFF, a multipurpose tangential flow filtration (TFF) GMP system, in response to rising industry demand for gene therapy, vaccine, and mRNA-based therapeutics.
In November 2023, Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced the commercial launch of TangenX SC, the industry’s first holder-free, self-contained Tangential Flow Filtration (TFF) device. The technology is especially suited to the manufacture of biologics where fully closed systems are critical or ideal, including antibody drug conjugates (ADCs), viral vectors, nucleic acids and lipid nanoparticles, and can also be applied to monoclonal antibody, and recombinant protein production.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35H2128